PEG-derivative effectively modifies the characteristics of indomethacin-PLGA microspheres destined to intra-articular administration

Author: Puebla Patricia   Pastoriza Pilar   Barcia Emilia   Fernández-Carballido Ana  

Publisher: Informa Healthcare

ISSN: 1464-5246

Source: Journal of Microencapsulation, Vol.22, Iss.7, 2005-11, pp. : 793-808

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

The aim of this study was to obtain biodegradable indomethacin microspheres for intra-articular administration in rheumatoid arthritis, where angiogenic processes are involved. Indomethacin concentrations to achieve an anti-angiogenic effect would be five-times higher than an anti-inflammatory. Microspheres were prepared by solvent evaporation using PLGA. Indomethacin is a poor water-soluble drug with it being possible that dissolved and non-dissolved drug co-exist within the polymeric matrix resulting in rapid release. To control this release, an oil-PEG-derivative was incorporated, producing changes in morphology, crystallinity and indomethacin release. To minimize the amount of microspheres administered, a two-factor five-level central rotable composite 2 2 ?+?star design was employed with two independent variables: indomethacin percentage and PEG-derivative percentage. The optimum formulation showed mean encapsulation efficiency of 94.3?±?2.2% and released 7.99?±?0.25?µg indomethacin/day/mg microspheres for 21 days. A dose of 20–50?mg of this formulation could be appropriate to achieve both anti-angiogenic and anti-inflammatory effects. Preliminary cytotoxicity studies performed in rat splenocytes showed an adequate cell viability.

Related content